Anti-dsDNA Antibodies in Systemic Lupus Erythematosus

Pathophysiological Mechanism

SLE represents a chronic autoimmune disorder where the immune system loses its ability to distinguish self from non-self, resulting in production of multiple autoantibodies against nuclear antigens, including anti-dsDNA antibodies, which are among the most specific autoantibodies produced in this process 1, 2
Anti-dsDNA antibodies are produced as part of the fundamental autoimmune dysregulation that characterizes SLE, where loss of immune tolerance leads to B cells generating autoantibodies against nuclear components, particularly double-stranded DNA 1, 2
These antibodies can develop years before clinical diagnosis, and studies show that anti-dsDNA antibodies appearing in virtually all SLE patients at some point during their disease course 1

Changes in anti-dsDNA antibody titers often correlate with disease activity and active renal disease, making them useful for monitoring, as recommended by the European League Against Rheumatism 3
The American College of Rheumatology suggests that patients with elevated anti-dsDNA levels should be closely monitored for signs of active disease, particularly renal disease 3

Some patients exhibit "serologically active, clinically quiescent" SLE with elevated anti-dsDNA but no clinical symptoms, and the available data do not support treating patients with anti-dsDNA antibodies in the absence of clinical activity, according to the American College of Rheumatology 3
The European League Against Rheumatism notes that anti-dsDNA antibodies can be found in disorders besides SLE, including infections and other autoimmune conditions, which contributes to diagnostic complexity 1, 2

Anti-dsDNA antibodies should be monitored quantitatively every 6-12 months using the same laboratory method to ensure result comparability, as recommended by the European League Against Rheumatism 4, 5
The American College of Rheumatology suggests that complement levels should be assessed alongside anti-dsDNA, even if previously normal, as low complement often correlates with active disease 3